• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Expression of mutant P53 gene protein product in human bladder carcinoma].

作者信息

Ye D W

机构信息

Changhai Hospital, Second Military Medical College, Shanghai.

出版信息

Zhonghua Wai Ke Za Zhi. 1993 Aug;31(8):484-6.

PMID:8112175
Abstract

Expression of P53 protein was detected immunohistochemically in formalin-fixed, paraffin-embedded tissues from 67 patients with bladder carcinoma and 6 normal bladder controls. P53 protein was found positively in 34 of the 67 tumors, whereas no normal bladder controls and no non-cancer tissue cells on tumor sections was stained positively for P53 protein. The percentage of staining for P53 was higher in poorly-differentiated and in invasive tumors than in well and moderately differentiated and in superficial tumors. We also found that P53 positive staining was closely related to tumors recurrence. Hence, the expression of P53 may be used as a tumor marker predicting the histograde, clinical stage and recurrence.

摘要

相似文献

1
[Expression of mutant P53 gene protein product in human bladder carcinoma].
Zhonghua Wai Ke Za Zhi. 1993 Aug;31(8):484-6.
2
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.p53基因与蛋白状态:p53改变在预测膀胱癌患者预后中的作用
J Clin Oncol. 2007 Dec 1;25(34):5352-8. doi: 10.1200/JCO.2006.10.4125.
3
The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma.临床分期为T2和T3a期的移行细胞膀胱癌中p53过表达与淋巴结转移的关系。
J Exp Clin Cancer Res. 1999 Sep;18(3):391-5.
4
Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guérin (BCG).卡介苗(BCG)治疗浅表性膀胱癌时,治疗前p53核过表达作为一种预后标志物。
Eur Urol. 2004 Apr;45(4):475-82. doi: 10.1016/j.eururo.2003.11.018.
5
Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins.
J Urol. 1996 Nov;156(5):1846-9.
6
Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.血管内皮生长因子、受体KDR和p53蛋白在膀胱移行细胞癌中的表达
Urol Int. 2008;81(1):72-6. doi: 10.1159/000137644. Epub 2008 Jul 16.
7
The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.p53肿瘤抑制基因与核蛋白:基础科学综述及其在膀胱癌治疗中的相关性
J Urol. 2003 Apr;169(4):1219-28. doi: 10.1097/01.ju.0000056085.58221.80.
8
p53 gene mutation in recurrent superficial bladder cancer.复发性浅表性膀胱癌中的p53基因突变
J Urol. 1995 May;153(5):1711-5.
9
The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.p53和bcl-2在浅表性膀胱移行细胞癌中的表达及其在术后膀胱内化疗结局中的作用。
Anticancer Res. 1998 Nov-Dec;18(6B):4717-21.
10
Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.免疫组织化学检测p53蛋白在膀胱尿路上皮癌患者中的敏感性和特异性。
Urol Int. 2007;79(4):321-7. doi: 10.1159/000109717.